共 50 条
- [1] One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy BMC PHARMACOLOGY & TOXICOLOGY, 2019, 20 (1):
- [2] One-year outcome of combination therapy with intravitreal aflibercept and verteporfin photodynamic therapy for polypoidal choroidal vasculopathy Graefe's Archive for Clinical and Experimental Ophthalmology, 2017, 255 : 541 - 548
- [4] Comparison of One-Year Outcome of Intravitreal Aflibercept with or without Photodynamic Therapy for Polypoidal Choroidal Vasculopathy MEDICINA-LITHUANIA, 2024, 60 (08):
- [5] One-Year Outcome of Aflibercept and Photodynamic Therapy in a Caucasian Patient with Polypoidal Choroidal Vasculopathy Refractory to Ranibizumab and Photodynamic Therapy CASE REPORTS IN OPHTHALMOLOGY, 2018, 9 (01): : 172 - 178
- [6] Comparison of Two-Year Outcome of Photodynamic Therapy in Combination with Intravitreal Aflibercept or Ranibizumab for Polypoidal Choroidal Vasculopathy APPLIED SCIENCES-BASEL, 2021, 11 (03): : 1 - 9
- [7] ONE-YEAR RESULTS OF INTRAVITREAL AFLIBERCEPT FOR POLYPOIDAL CHOROIDAL VASCULOPATHY RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (01): : 37 - 45